Alternative medicines such as herbal/natural cures historically predates conventional medicinal products (medicines backed with scientific data). In Germany, 70% of physicians prescribes herbal medicine to patients, and in the USA,… read more →
It has been scientifically established that women predominantly have osteoporosis because of several factors including menopause which occurs on average, at the age 51 (NIH, 2011). The age-associated factor of… read more →
Abstract Offshoring of clinical trials is becoming an attractive business, and strategic models to facilitate cost efficient R&D processes and clinical trials. Based on the pharmaceutical industry’s data, the financial… read more →
Abstract Stakeholder is an intricate part of a clinical research. In many cases, without the stakeholder’s active-participatory role, a clinical research trial or an invention may not be possible. To… read more →
Most of the prescription drugs today give a short-term relief to patients thereby increasing the odds for patients to be addicted to prescription drugs. In addition, people who die from… read more →
Alzheimer research is worthy of receiving funding from all funding sources not just because any potential new chemical entity may show a promising result but because the disease has been… read more →
There are hundreds of pharmaceutical products made from plants/herbal sources. The following list includes some of pharmaceutical products derived from plants and herbal sources. Drug/Chemical Action Plant Source Acetyldigoxin Cardiotonic… read more →
In pharmacology, “me-too” medicinal product is identical to a branded or generic version of a product in terms of its mode of action, mechanism of action or clinical pathway. Me-too… read more →
Abstract The most desirable benefit that patients will hope for in relation to the cost of pharmaceutical products are outcome reach and evaluation of improvements based of quality of life… read more →
Risk analysis is a systematic methodology used in an attempt to assess the hazardous or potential harm of an investigational product (Whitmore, 2004). Risk is a relative term in the… read more →
Recent Comments